In June 2014 an integrated global pharma company from India Dr. Reddys had reportedly acquired rights and re-launched lotion for vitiligo called Melgain. Generic name is Decapeptide, using the Basic Fibroblast Growth Factor or bFGF, a substance the body naturally produces for maintaining the structure and function of melanin producing cells. Repigmentation is attributed to the growth of melanocytes in depigmented hair roots in the vitiligo patch and also the skin directly surrounding the patch. Patients generally receive better and faster repigmentation, especially when bGFG is used in combination with other medical treatment options. The average cost in India is $12 for 5mg (5mL.)
As if in response to this move (or vice versa, we are not really sure on this), US-based company PhotoMedex has recently announced bringing its laser treatment technology VTRACK to India on a massive scale. Company's local subsidiary has set up five certified clinics in Hyderabad on a franchisee basis, and look forward to adding more in the next 4-5 years. It's new campaign 'Live Clear. Live Free.' drives awareness of the standard of care for vitiligo, attracting dermatologists to vitiligo discipline nationwide. The company stated full benefit of the vitiligo treatment would take 10-20 sessions. VTRACK uses UVB range of 280 315 nm. Each sessions costs Rs 2,400 or approximately $40.
- Will it spread?
Vitiligo activity may vary considerably from person to person. In a good number of patients the disease goes on for 3-4 years and then it settles down, with one or two stubborn...
- Polypodium leucotomos as an adjunct treatment for vitiligo?
Extracts of the tropical fern Polypodium leucotomos appear to have beneficial properties for the vitiligious skin. Polypodium leucotomos (also classified as Polypodium aureum) a...
- Which skin conditions can be mistaken for vitiligo?
Vitiligo is a common skin condition with characteristic milky white patches of irregular shape. However, several other skin conditions exhibit similar symptoms that can lead to ...
Our work is entirely funded by private donations – we receive no money from government. Your money will help us continue funding research into vitiligo and supporting people affected by the condition.
Though it is not always easy to treat vitiligo, there is much to be gained by clearly understanding the diagnosis, the future implications, treatment options and their outcomes.
Many people deal with vitiligo while remaining in the public eye, maintaining a positive outlook, and having a successful career.Copyright (C) Bodolóczki Júlia
By taking a little time to fill in the anonymous questionnaire, you can help researchers better understand and fight vitiligo.